Success examples
Into Deep Water: Optimizing BCL6 Inhibitors by Growing into a Solvated Pocket

Lloyd M. G., Huckvale R., Cheung K-M. J., Rodrigues M. J., Collie G. W., Pierrat O. A., Iou M. G., Carter M., Davis O. A., McAndrew P. C., Gunnell E., Le Bihan Y-V., Talbot R., Henley A. T., Johnson L. D., Hayes A., Bright M. D., Raynaud F. I., Meniconi M., Burke R., van Montfort R. L. M., Rossanese O. W., Bellenie B. R., Hoelder S.

J Med Chem. 2021, 64, 23, 17079-17097.

General literature
Chemical Probes for Understudied Kinases: Challenges and Opportunities

Serafim R. A. M., Elkins J. M., Zuercher W. J., Laufer S. A., Gehringer M.

J Med Chem. 2021, Online ahead of print.

Success examples
Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma

Pighi C., Cheong T.C., Compagno M., Patrucco E., Arigoni M., Olivero M., Wang Q., Lopez C., Bernhart S.H., Grande B.M., Poggio T., Langellotto F., Bonello L., Dall'Olio R., Martinez-Martin S., Molinaro L., Francia di Celle P., Whitfield J.R., Soucek L., Voena C., Calogero R.A., Morin R.D., Staudt L.M., Siebert R., Zamo A., Chiarle R.

Blood Adv 2021, 5(23):5239-5257.

General literature
Machine Learning Solicitation for COVID 19

Mohanty S. N., Saxena S. K., Satpathy S., Chatterjee J. M.

Springer 2021, ISBN 978-981-15-7316-3.

Success examples
Label-free cell assays to determine compound uptake or drug action using MALDI-TOF mass spectrometry

Unger M. S., Blank M., Enzlein T., Hopf C.

Nat Protoc 2021, Nov 10.

General literature
Label-free cell assays to determine compound uptake or drug action using MALDI-TOF mass spectrometry

Unger M. S., Blank M., Enzlein T., Hopf C.

Nat Protoc 2021, Nov 10.